King & Spalding is a proud sponsor of ACI’s 2^nd Annual Life Sciences AI Summit on February 20^th in New York City, where partners Amanda Klingler and Mark Sentenac will be featured speakers. Amanda will participate in a discussion on navigating FDA and EMA directives for AI in life sciences, and Mark will be part of a panel focusing on AI litigation and enforcement risks across the life sciences product lifecycle: from pre-commercialization to post-market.

More information can be found at: Life Sciences AI Summit